Co-Authors
This is a "connection" page, showing publications co-authored by Dinesh Chellappan and Sachin Singh.
Connection Strength
0.651
-
Middle East Respiratory Syndrome (MERS) Virus-Pathophysiological Axis and the Current Treatment Strategies. AAPS PharmSciTech. 2021 Jun 08; 22(5):173.
Score: 0.237
-
Emerging cases of mucormycosis under COVID-19 pandemic in India: Misuse of antibiotics. Drug Dev Res. 2021 11; 82(7):880-882.
Score: 0.060
-
Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19. Heliyon. 2021 Jul; 7(7):e07635.
Score: 0.060
-
Nuclear factor-kappa B and its role in inflammatory lung disease. Chem Biol Interact. 2021 Aug 25; 345:109568.
Score: 0.060
-
Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective. Life Sci. 2021 Sep 01; 280:119744.
Score: 0.060
-
A novel nano therapeutic using convalescent plasma derived exosomal (CPExo) for COVID-19: A combined hyperactive immune modulation and diagnostics. Chem Biol Interact. 2021 Aug 01; 344:109497.
Score: 0.059
-
Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio-renal damage in COVID-19 infection. Drug Dev Res. 2021 09; 82(6):784-788.
Score: 0.058
-
Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations. J Mol Neurosci. 2021 Nov; 71(11):2192-2209.
Score: 0.058